Dr. Cindy Bell is CCRA's New Chair

Modified on

At the December 2018 CCRA Member Meeting, Dr. Cindy Bell, Genome Canada's Executive Vice-President, Corporate Development, transitioned from Chair-elect to CCRA Chair. Dr. Bell was elected from among the organizational representatives and will serve a two-year term.

Members recognized the invaluable contributions of outgoing Chair, Dr. Stephen Robbins, Scientific Director, CIHR Institute of Cancer Research. Dr. Robbins will remain in the Past-Chair capacity until December 2019.